“anti-TNF drugs”的搜索结果，显示 81-90 项，共有 940 项

1. 普通内科 - 临床试验 - 妙佑医疗国际

   This study aims to demonstrate acceptability and feasibility of the use of Distance Reiki therapy versus sham Reiki therapy among multiple myeloma patients.It ...

2. 神经科- 临床试验- 妙佑医疗国际

   ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

3. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

4. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

5. 传染病- 临床试验- 妙佑医疗国际

   ... treatment variations, as well as the factors that ... The third aim is to measure SARS-CoV-2 anti-spike and anti ... treatment variations, as well as the ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... therapy, but this study will administer treatment in approximately 3 weeks. To achieve this shorter course, proton therapy is used. This study aims to ...

7. 肺科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine whether 2-drug therapy is non-inferior to 3-drug therapy against pulmonary mycobacterium avium complex (MAC) disease, ...

8. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

9. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

10. 乳腺专科门诊- 临床试验- 妙佑医疗国际

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...